Aptamers Market

Aptamers Market Overview (2022 to 2032)

The aptamers market is estimated to secure an impressive CAGR of 14.3% during the forecast period. The market projected a valuation of US$ 1.71 Billion in 2022 and is likely to be valued at US$ 6.51 Billion by 2032.

The high prevalence of chronic diseases, rising demand for novel diagnostic procedures, and investments in aptamers Research and Development are expected to uplift the aptamers market growth.

Aptamers are oligonucleotide or peptide compounds that bind to target nucleic acid, protein, and lipid molecules with a high level of specificity. Aptamers can form single-stranded loops and helices, which allows them to take on a variety of shapes. Rapidly produced aptamers are used for protein-specific detection, inhibition, and characterization of proteins. Aptamers can be used as functional proteomic levels with small molecules, pharmaceutical leads, detection reagents, and, antibodies, and other aptamers.

Aptamers can be used for both research and therapeutic purposes and are often produced by a selection procedure from a vast pool of random sequences.

The demand for aptamers is rising due to rising chronic diseases and growing demand for diagnostic procedures during the forecast period. The rapid aptamers used for protein characterization, protein-specific detection, and inhibition are growing the aptamers market size during the forecast period. The growing prevalence of diseases like cancer, CVD, and others is likely to increase the adoption of aptameric-based diagnostic products in recent years.

In addition, the growing demand for aptamers is rising due to recognizing molecular, antibodies, pharmaceutical leads, and detection reagents during the forecast period. On the other hand, aptamers are widely used for research and therapeutic purposes and are accelerating to drive market share.

The rising technological advancement, presence of prominent marketers, and low cost to attach molecules are accelerating the demand for aptamers during the forecast period. The innovation of new drugs and recent developments in production and purification in the biotechnology and pharmaceutical sectors are boosting the aptamers market growth.

Moreover, the increasing recombinant products and rising approvals of new products by the FDA also promote market expansion during the forecast period. The adoption of Nanotechnology and the high demand for aptamers in medical applications are driving the market opportunities.

The diagnostic segment in application type dominates the global market by securing a healthy share during the forecast period. The diagnosis is one of the preferred crucial factors in treating a patient's disease in recent times. It used several therapeutic and diagnostic applications with various strategies to accelerate the market growth during the forecast period.

North America leads the global market by contributing a significant share during the forecast period. The rising chronic disease, healthcare infrastructure, and growing research laboratories are booming the North American market during the forecast period. The increased demand for aptamers therapies, government policies, and the presence of key manufacturers to manufacture new aptamers products are growing the market opportunities.

The presence of key players in the global market plays a crucial role by contributing a maximum output during the forecast period. The players focus on the end user's expectations and develop better products and services that drive patient satisfaction during the forecast period.

However, these key players are using several marketing tactics to upsurge the market size to another height. The adoption of marketing tactics includes mergers, partnerships, collaborations, agreements, product launches, and acquisitions. These players are continuing to add value to the market in the coming years.

What are the Factors Responsible for the Growth of the Aptamers Market?

The primary drivers of the market value for aptamers are the high efficiency and low cost to attach large molecules as compared to antibodies, together with an increased focus on technological advancement. Many scientists are interested in aptamers due to their competitive advantages in recent developments in the purification, production, and drug delivery for killing target cells. Furthermore, the market for aptamers has expanded as a result of improved research and development capabilities in the pharmaceutical as well as biotechnology industries.

The prevalence of diseases like CVD, cancer, and AMD may rise, increasing the number of patients who require diagnosis in laboratories, and as a result the need for aptameric-based diagnostic products increases. A lucrative market for aptamers has been opened up by the emerging focus on aptamers for the treatment of diseases and discovery of new drugs as well as by the increased manufacture of recombinant products. Increasing FDA approvals have also promoted market expansion and accelerated the rate of market growth.

Which Region Shows Strong Growth Potential in the Aptamers Market?

Due to the rising prevalence of chronic diseases, the growing interest of research laboratories in the field of aptamers and strong healthcare infrastructure in North America dominated the aptamers market. The market is anticipated to grow the fastest in Europe during the forecast period due to the increasing demand for aptamer therapies and the approval of new aptamer-based products.

The growth of the East and South Asia region is attributable to the expanded opportunities in diagnostic and pharmaceutical development, supportive government policies as well as the presence of well-established key manufacturers in this region.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Manufacturers of the Aptamers Market?

Some of the key players operating in the aptamers market are NeoVentures Biotechnology Inc., TriLink BioTechnologies., Aptagen, Creative Biogene, AuramerBio, 2bind GmbH, IBA GmbH, AMS Biotechnology Limited, Aptamer Group, Barrick Lab, Aptamer Sciences, Inc., Vivonics Inc., SomaLogic, Inc., Donovan Biotechnology, LLC, and others.

Scope of Report

Key Segments Covered in the Aptamers Industry Survey

By Type:

• Nucleic Acid Aptamer
  • DNA
  • RNA
  • XNA
• Peptide Aptamer

By Technology:

• SELEX
• Others

By Application:

• Diagnostics
• Research and Development
• Therapeutics
• Other

By End User:

• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research
• Organizations
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa